News
Treatment sequence with romosozumab influences osteoporosis outcomes
- Author:
- Neil Osterweil
Administering anabolic agents followed by antiresorptives is associated with higher gains in bone mineral density and improved bone-turnover...
News
Warfarin use linked to knee and hip replacement in osteoarthritis patients
- Author:
- Neil Osterweil
Results of a large nested, case-control study provide further evidence of the role of vitamin K in reducing osteoarthritis progression,...
News
Lupus-specific predictors for CVD described in Black patients
- Author:
- Neil Osterweil
Discoid rash and renal disorder predicted stroke, and neurologic and immunologic disorder predicted ischemic heart disease in Black patients with...
News
Aging with HIV adds to comorbidity burden
- Author:
- Neil Osterweil
Interventions need to focus on narrowing the gap in comorbidity-free years between aging populations with and...
News
Preemptive CMV monitoring beats prophylaxis post liver transplant
- Author:
- Neil Osterweil
CMV disease incidence was lower among patients treated only when CMV viremia was detected compared with those...
News
Potentially practice-changing bacterial therapy trials analyzed
- Author:
- Neil Osterweil
Intravenous fosfomycin could improve treatment of complicated UTIs, but adjunctive inhaled amikacin did not...
News
Lower BP and better tumor control with drug combo?
- Author:
- Neil Osterweil
Angiotensin II receptor blockers were associated with better responses and survival in patients receiving immune...
News
TDF preferred in PrEP for Blacks and women, studies indicate
- Author:
- Neil Osterweil
Significant weight gain with the newer prodrug of tenofovir, TAF, puts Black women at especially high risk for...
News
Shared decision-making aids choice of PrEP
- Author:
- Neil Osterweil
Direct-to-consumer advertising has complicated the clinician-patient discussion regarding pre-exposure...
Article
Teen vaping in the time of COVID-19
- Author:
- Neil Osterweil
E-cigarette use among adolescents and young adults was on the wane until the COVID-19 pandemic occurred...
News
Switch to integrase inhibitor regimen safe and effective
- Author:
- Neil Osterweil
Forty-eight weeks after the switch, virologic suppression was maintained among 94.3% of those on an integrase inhibitor–based regimen.
News
Chemoradiation boosts glioblastoma survival in real-world setting
- Author:
- Neil Osterweil
Registry data in the U.S. and Europe showed increasing survival as combined temozolomide and radiation made its...
News
New first-line standard of care for esophageal cancer?
- Author:
- Neil Osterweil
Adding pembrolizumab to chemotherapy improved overall and progression-free survival in patients with previously...
News
Sotorasib is a ‘triumph of drug discovery’ in cancer
- Author:
- Neil Osterweil
Sotorasib, an agent targeting the KRAS p.G12C mutation, demonstrated activity against non–small cell lung cancer...
News
Nivo-cabo combo joins advanced RCC treatment ranks
- Author:
- Neil Osterweil
Nivolumab plus cabozantinib bested sunitinib in patients with previously untreated advanced or metastatic renal...